Skip to main content
Clinical Trials/ITMCTR2000004058
ITMCTR2000004058
Recruiting
Phase 1

Study on Bone Metabolic Mechanism and Clinical Application of Qianggu Yin in the treatment of Primary Type I Osteoporosis

The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Primary type I osteoporosis
Sponsor
The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • According to the diagnostic criteria of osteoporosis; postmenopausal women; 55\-65 years old.

Exclusion Criteria

  • 1\.Diabetes mellitus, Cushing syndrome, changes in thyroid or parathyroid function, osteomalacia, rheumatoid arthritis, multiple myeloma, bone tumor, osteoarthropathy, Paget's disease, osteogenesis imperfecta and other diseases that seriously affect bone or calcium metabolism;
  • 2\.has taken estrogen, steroid hormone, calcitonin, parathyroid hormone, and both in the past 6 months Phosphate, fluoride, vitamin D, anticonvulsants, diuretics and other drugs that affect bone metabolism;
  • 3\.combined with cardiovascular, cerebrovascular, hematopoietic system and other serious primary type I disease; combined with severe liver and kidney dysfunction; mental illness or Alzheimer's disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials